PATENT CLAIM ANALYSIS

Application Number: 16376478
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "291000"]

Abstract:
The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject.

Claim (Index 37):
The inhalation solution according to  claim 31 , wherein the volume of the inhalation solution is between about 0.1 ml to about 5 ml.

Metadata:
- Claim Count in Document: 149.0
- Percentile: 100.0
- Lexical Diversity: 1.43478
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15663246', '15972738', '15157143', '15783146', '11506128']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8181609997566672
- 35 USC 102 Novelty (BERT): 0.558232598705135
- Combined Prediction Score: 0.792168159651514
- Mean Citation Score: 379.661482
- Max Citation Score: 460.86743
- Similarity Product: 315.0447212345898

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test